SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001654954-23-003730
Filing Date
2023-03-28
Accepted
2023-03-28 17:28:59
Documents
17
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A drma_10ka.htm   iXBRL 10-K/A 87594
2 EX-31.1 drma_ex311.htm EX-31.1 8653
3 EX-31.2 drma_ex312.htm EX-31.2 8655
4 EX-32.1 drma_ex321.htm EX-32.1 5342
  Complete submission text file 0001654954-23-003730.txt   324861

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA drma-20221231.xsd EX-101.SCH 5959
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20221231_lab.xml EX-101.LAB 24247
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20221231_cal.xml EX-101.CAL 898
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20221231_pre.xml EX-101.PRE 17557
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20221231_def.xml EX-101.DEF 3897
11 EXTRACTED XBRL INSTANCE DOCUMENT drma_10ka_htm.xml XML 8139
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40739 | Film No.: 23770786
SIC: 2834 Pharmaceutical Preparations